Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria-history, rationale, description, and significance, Sleep Med, vol.15, pp.860-873, 2014. ,
Restless legs syndrome prevalence and impact: Rest general population study, Arch. Intern. Med, vol.165, pp.1286-1292, 2005. ,
Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria, Mov. Disord, vol.12, pp.61-65, 1997. ,
Restless legs syndrome: Update on pathogenesis, Curr. Opin. Pulm. Med, vol.19, pp.594-600, 2013. ,
Comorbidities, treatment, and pathophysiology in restless legs syndrome, Lancet Neurol, vol.17, pp.994-1005, 2018. ,
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: A meta-analysis, Lancet Neurol, vol.16, pp.898-907, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01832985
Iron and restless legs syndrome: Treatment, genetics and pathophysiology, Sleep Med, vol.31, pp.61-70, 2017. ,
A clinical evaluation of serum ferritin as an index of iron stores, N. Engl. J. Med, vol.290, pp.1213-1216, 1974. ,
Association between serum hepcidin level and restless legs syndrome, Mov. Disord, vol.33, pp.618-627, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01842236
Are serum ferritin and transferrin saturation risk markers for restless legs syndrome in young adults? Longitudinal and cross-sectional data from the Western Australian Pregnancy Cohort (Raine) Study, J. Sleep Res, vol.28, p.12741, 2019. ,
Prevalence of restless legs syndrome and associated factors in an otherwise healthy population: Results from the Danish Blood Donor Study, Sleep Med, vol.36, pp.55-61, 2017. ,
Prevalence of restless legs syndrome among adults in Iceland and Sweden: Lung function, comorbidity, ferritin, biomarkers and quality of life, Sleep Med, vol.11, pp.1043-1048, 2010. ,
Iron metabolism and the risk of Restless Legs Syndrome in an elderly general population-The MEMO-Study, J. Neurol, vol.249, pp.1195-1199, 2002. ,
The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: Association with ferritin levels, Sleep Med, vol.10, pp.611-615, 2009. ,
French consensus: Augmentation syndrome in restless legs syndrome, Rev. Neurol, vol.174, pp.532-539, 2018. ,
The long-term treatment of restless legs syndrome/Willis-Ekbom disease: Evidence-based guidelines and clinical consensus best practice guidance: A report from the International Restless Legs Syndrome Study Group, Sleep Med, vol.14, pp.675-684, 2013. ,
Two to Tango: Regulation of mammalian iron metabolism, Cell, vol.142, pp.24-38, 2010. ,
Hepcidin in human iron disorders: Diagnostic implications, Clin. Chem, vol.57, pp.1650-1669, 2011. ,
Toward worldwide hepcidin assay harmonization: Identification of a commutable secondary reference material, Clin. Chem, vol.62, pp.993-1001, 2016. ,
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome, Ann. Hematol, vol.92, pp.1617-1623, 2013. ,
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation, Clin. Psychol. Rev, vol.8, pp.77-100, 1988. ,
A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale, Sleep, vol.14, pp.540-545, 1991. ,
Validation of the Insomnia Severity Index as an outcome measure for insomnia research, Sleep Med, vol.2, pp.297-307, 2001. ,
The AASM manual for the scoring of sleep and associated events: Rules, terminology and technical specifications, Westchest Ill Am. Acad. Sleep Med, 2007. ,
The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG), Sleep Med, vol.7, pp.175-183, 2006. ,
Clinical measurement of Hepcidin-25 in human serum: Is quantitative mass spectrometry up to the job?, EuPA Open Proteomics, vol.3, pp.60-67, 2014. ,
Serum hepcidin: Reference ranges and biochemical correlates in the general population, Blood, vol.117, pp.218-225, 2011. ,
High sensitivity hepcidin-25 bioactive elisas: Manual and fully automated system for the quantification of hepcidin-25 in human serum and plasma, Blood, vol.128, pp.4820-4820, 2016. ,
Validation of a competitive ELISA assay for the quantification of human serum hepcidin. Scand, J. Clin. Lab. Investig, vol.75, pp.652-658, 2015. ,
Hepcidin in the diagnosis of iron disorders, Blood, vol.127, pp.2809-2813, 2016. ,
Increased serum hepcidin levels in subjects with the metabolic syndrome: A population study, PLoS ONE, vol.7, p.48250, 2012. ,
Macrophage iron, hepcidin, and atherosclerotic plaque stability, Exp. Biol. Med, vol.232, pp.1014-1020, 2007. ,
Iron and hepcidin as risk factors in atherosclerosis: What do the genes say?, BMC Genet, vol.16, p.79, 2015. ,
, Scientific RepoRtS |, vol.10, 2020.
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin, J. Clin. Investig, vol.113, pp.1271-1276, 2004. ,
The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation, J. Clin. Investig, vol.110, pp.1037-1044, 2002. ,
Hepcidin-a well-known iron biomarker with prognostic implications in chronic kidney disease, Nephrol. Dial. Transplant, vol.28, pp.2936-2939, 2013. ,
Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients, Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc, vol.28, pp.3062-3071, 2013. ,
Iron metabolism, hepcidin, and mortality (the Ludwigshafen Risk and Cardiovascular Health Study), Clin. Chem, vol.65, issue.7, pp.849-861, 2019. ,